Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

Ilaria Marigo, Luigi Dolcetti, Paolo Serafini, Paola Zanovello, Vincenzo Bronte

Research output: Contribution to journalArticle

456 Citations (Scopus)

Abstract

Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.

Original languageEnglish
Pages (from-to)162-179
Number of pages18
JournalImmunological Reviews
Volume222
Issue number1
DOIs
StatePublished - Apr 1 2008

Fingerprint

Immune Tolerance
Neoplasms
Myeloid-Derived Suppressor Cells
Immunotherapy
Dendritic Cells
Macrophages
Lymphocytes

Keywords

  • Arginine metabolism
  • Cancer
  • Immunosuppression
  • MDSC
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. / Marigo, Ilaria; Dolcetti, Luigi; Serafini, Paolo; Zanovello, Paola; Bronte, Vincenzo.

In: Immunological Reviews, Vol. 222, No. 1, 01.04.2008, p. 162-179.

Research output: Contribution to journalArticle

Marigo, Ilaria ; Dolcetti, Luigi ; Serafini, Paolo ; Zanovello, Paola ; Bronte, Vincenzo. / Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. In: Immunological Reviews. 2008 ; Vol. 222, No. 1. pp. 162-179.
@article{89305ed9d0da407b9bf2066c9580b823,
title = "Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells",
abstract = "Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.",
keywords = "Arginine metabolism, Cancer, Immunosuppression, MDSC, Tolerance",
author = "Ilaria Marigo and Luigi Dolcetti and Paolo Serafini and Paola Zanovello and Vincenzo Bronte",
year = "2008",
month = "4",
day = "1",
doi = "10.1111/j.1600-065X.2008.00602.x",
language = "English",
volume = "222",
pages = "162--179",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

AU - Marigo, Ilaria

AU - Dolcetti, Luigi

AU - Serafini, Paolo

AU - Zanovello, Paola

AU - Bronte, Vincenzo

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.

AB - Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.

KW - Arginine metabolism

KW - Cancer

KW - Immunosuppression

KW - MDSC

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=41149119143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149119143&partnerID=8YFLogxK

U2 - 10.1111/j.1600-065X.2008.00602.x

DO - 10.1111/j.1600-065X.2008.00602.x

M3 - Article

C2 - 18364001

AN - SCOPUS:41149119143

VL - 222

SP - 162

EP - 179

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -